Maternal, Fetal and Neonatal Outcomes in Pregnant Women With Systemic Lupus Erythematosus: A Comprehensive Review Study Publisher



Karimi FZ¹ ; Saeidi M² ; Mirteimouri M³ ; Malekisaghooni N⁴ Show Affiliations
Source: International Journal of Pediatrics Published:2017

Abstract

Background: Systemic lupus erythematosus (SLE) is an autoimmune disease with multiple organ involvement and periods of relapse and remission that mainly affects young women of childbearing age. In this regard the reproductive health is an important issue. Although diagnosis, treatment and management of pregnancy in SLE women have been improved recently, but the main concern is effects of SLE on maternal, fetal and neonatal outcomes. This study aimed to investigate the maternal, fetal and neonatal outcomes in pregnant women with SLE. Materials and Methods: The databases of PubMed, Medline, Scopus and Web of Science as well as domestic database (Persian) such as SID, Iranmedex, Magiran, Irandoc, and Google Scholar were searched with using keywords such as Systemic lupus erythematosus Pregnancy Neonatal lupus maternal, fetus or neonatal outcome and equivalent Persian words. Included were all Persian and English articles, published between 2000 and May 2017. Finally, a total of 77 studies were ultimately included. Results: Adverse perinatal outcomes increase in pregnancies with lupus. Maternal outcomes include respiratory, cardiovascular, blood and skin disorders; stillbirth, spontaneous, and recurrent abortion in fetus and in neonate include neonatal lupus, prematurity, intrauterine growth restriction (IUGR), and small for gestational age (SGA). Conclusion: Pregnant women with SLE are at high risk due to increased complications for both the mother and fetus. It seems complete control of the women before fertilization, so that they are at full remission in the beginning of pregnancy and the disease activity is in completely controlled, it can help to improve outcomes of pregnancy and so better results can be expected.